相关实验视频
Updated: Mar 17, 2026

08:50
Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
16.9K
[血清中非常长链和脂肪酸与慢性病之间的关系]
Kaixiang Liu1, Yi Wang1, Li Wang1,2
1( 610054)School of Medicine, University of Electronic Science and Technology of China, Chengdu 610054, China.
概括
在美国成年人中,较高水平的长链和脂肪酸 (VLCSFA) 与慢性病 (CKD) 的风险较低有关. 这些发现表明,VLCSFA在预防CKD方面具有潜在的保护作用.
科学领域:
- 生物化学 生化学
- 腎臟病學 (nephrology) 是一種醫學專業.
- 流行病学 流行病学
背景情况:
- 慢性病 (CKD) 是一个重要的全球健康问题.
- 了解特定生物标志物的作用,例如非常长链和脂肪酸 (VLCSFA),对于预防和管理CKD至关重要.
研究的目的:
- 调查血清VLCSFA水平与美国成年人中CKD患病率之间的关联.
- 确定可能影响CKD风险的特定VLCSFA.
主要方法:
- 利用了2011-2014年国家健康和营养检查调查 (NHANES) 的数据.
- 采用加权多变量逻辑回归,XGBoost机器学习和限制立方线 (RCS) 来分析VLCSFA和CKD之间的关系.
- 计算了估计的淋巴膜过率 (eGFR),并分析了各种共同变量.
主要成果:
- 对4164名参与者的分析显示,CKD和非CKD组之间血清VLCSFA的显著差异.
- 增加的VLCSFAs水平,特别是多可萨诺酸,三可萨诺酸和红酸,与慢性结核病的风险降低有关.
- XGBoost模型将三康坦酸确定为CKD风险的关键因素;子组分析显示主要在高血压CKD患者中具有保护作用.
结论:
- 血清VLCSFA的升高与美国成年人中CKD风险降低有关.
- 特定的VLCSFA显示出潜在的保护作用,特别是在高血压患者中.
- 需要进一步的大规模前性研究来证实这些发现.
相关概念视频
Chronic Kidney Disease I: Introduction
971
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
971
Chronic Kidney Disease II: Clinical Manifestations
880
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
880
Chronic Kidney Disease III: Interprofessional Care
581
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
581
Chronic Kidney Disease IV: Nursing Management
548
Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
548
Nephrotic Syndrome I : Introduction
836
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
836
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
248
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
248

